Interferon Regulatory Factor-1 Activates Autophagy to Aggravate Hepatic Ischemia-Reperfusion Injury Via the P38/P62 Pathway in Mice.

Yao Yu,Shipeng Li,Zhen Wang,Jindan He,Yijie Ding,Haiming Zhang,Wenli Yu,Yiwei Shi,Zilin Cui,Ximo Wang,Zhiliang Wang,Liying Sun,Rongxin Zhang,Hongyin Du,Zhijun Zhu

DOI: https://doi.org/10.1038/srep43684

IF: 4.6

2017-01-01

Scientific Reports

Abstract:Increasing evidence has linked autophagy to a detrimental role in hepatic ischemia- reperfusion (IR) injury (IRI). Here we focus on the role of interferon regulatory factor-1 (IRF-1) in regulating autophagy to aggravate hepatic IRI. We found that IRF-1 was up-regulated during hepatic IRI and was associated with an activation of the autophagic signaling. This increased IRF-1 expression, which was allied with high autophagic activity, amplified liver damage to IR, an effect which was abrogated by IRF-1 depletion. Moreover, IRF-1 contributed to P38 induced autophagic and apoptotic cell death, that can play a key role in liver dysfunction. The levels of P62 mRNA and protein were increased when P38 was activated and decreased when P38 was inhibited by SB203580. We conclude that IRF-1 functioned as a trigger to activate autophagy via P38 activation and that P62 was required for this P38-mediated autophagy. IRF-1 appears to exert a pivotal role in hepatic IRI, by predisposing hepatocytes to activate an autophagic pathway. Such an effect promotes autophagic cell death through the P38/P62 pathway. The identification of this novel pathway, that links expression levels of IRF-1 with autophagy, may provide new insights for the generation of novel protective therapies directed against hepatic IRI.